SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                  FORM 10-QSB

(Mark One)
 X   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
---  EXCHANGE ACT OF 1934


For the quarterly period ended               December 31, 2002
                               -------------------------------------------------

     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
---  EXCHANGE ACT OF 1934

For the transition period  from                         to
                                -----------------------    ---------------------

Commission file number                         0-16286
                       ---------------------------------------------------------

                              MEDPLUS CORPORATION
--------------------------------------------------------------------------------
               (Exact name of registrant as specified in its charter)

          Delaware                                       95-4082020
--------------------------------------------------------------------------------
(State or other jurisdiction of             (IRS Employer identification number)
 incorporation or organization)


6302     Mesedge Drive, Colorado Springs,  Colorado                80919
---------------------------------------------------                -----
(address of principle executive offices)                         (Zip Code)

                                  719-447-8856
--------------------------------------------------------------------------------
              (Registrants telephone number, including area code)

121 East Pikes Peak,  Ste. 355, Colorado Springs,  Colorado         80903
--------------------------------------------------------------------------------
Former name, former address and former fiscal year, (if changed since last
report)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by section 13 or 15 (d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.   Yes   X   No
                                          ---      ---

                       APPLICABLE ONLY TO ISSUERS INVOLVED
                        IN BANKRUPTCY PROCEEDINGS DURING
                            THE PRECEDING FIVE YEARS

Indicate by check mark whether the registrant has filed all documents and
reports required to be filed by section 13 or 15 (d) of the Securities Exchange
Act of 1934 subsequent to the distribution requirements under a plan confirmed
by a court.   Yes       No
                   ---      ---

                      APPLICABLE ONLY TO CORPORATE ISSUERS

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.
  Class                                        Outstanding at December 31, 2002
--------------------------------------------------------------------------------
  Common Stock, Par-Value
--------------------------------------------------------------------------------
  $.001 per share                              32,338,958
--------------------------------------------------------------------------------


<PAGE>
                               MEDPLUS CORPORATION

                              REPORT ON FORM 10-QSB


                                TABLE OF CONTENTS


PART I                                                  PAGE NUMBER
------                                                  -----------

ITEM 1.-FINANCIAL INFORMATION

        Balance Sheets at December 31, 2002 . . . . . . . . . . 3

        Statements of Operations for the
          Nine Months Ended December 31, 2002
          and December 31, 2001 and for Three
          Months Ended December 31, 2002
          and December 31, 2001 . . . . . . . . . . . . . . . . 4

        Statements of Cash Flows for the
          Nine Months Ended December 31, 2002
          and December 31, 2001 . . . . . . . . . . . . . . . . 4

        Notes to Financial Statements. . . . . . . . . . . . .  5

ITEM 2.-MANAGEMENT'S DISCUSSION AND ANALYSIS OF THE
              FINANCIAL CONDITION AND RESULTS OF
              OPERATIONS . . . . . . . . . . . . . . . . . . . .6

PART II
-------

              Other Information . . . . . . . . . . . . . . . . 6

              Signature Page . . . . . . . . . . . . . . . . .  6


                                        2
<PAGE>
<TABLE>
<CAPTION>
                                     PART I
                          ITEM 1. FINANCIAL INFORMATION
                              MEDPLUS CORPORATION

BALANCE SHEETS

ASSETS                                                December, 2002
                                                       (Unaudited)
<S>                                                  <C>
CURRENT ASSETS:
Cash and cash equivalents                            $         3,977
Note receivable                                               35,000
                                                     ----------------

Total current assets                                          38,977
                                                     ----------------

PROPERTY:
Office Equipment                                                   0
Furniture and Fixtures                                             0
                                                     ----------------

Total                                                              0
Less accumulated depreciation                                      0
                                                     ----------------

TOTAL ASSETS                                         $        38,977
                                                     ================

LIABILITIES AND SHAREHOLDERS' EQUITY

CURRENT LIABILITIES:
Accrued expenses                                     $       319,085
Notes payable -Related parties                               116,741
Accrued Payroll Taxes                                         94,500
Shareholder Loans                                             21,429
                                                     ----------------

Total liabilities                                            551,755
                                                     ----------------


SHAREHOLDERS' EQUITY:
Preferred stock, $.001 par value;
authorized 2,000,000 shares; no shares outstanding
Common stock, $.001 par value;
  authorized, 100,000,000 shares;
  32,338,958 issued and outstanding                           32,339
Additional paid in capital                                10,673,147
Accumulated deficit                                      (11,218,264)
                                                     ----------------

Net shareholders' equity (deficit)                          (512,778)
                                                     ----------------

TOTAL                                                $        38,977
                                                     ================
</TABLE>

                 See accompanying notes to financial statements


                                        3
<PAGE>
<TABLE>
<CAPTION>
                              MEDPLUS CORPORATION

                      STATEMENTS OF OPERATIONS (UNAUDITED)

                                    Three Month Period          Nine Month Period
                                    Ended December 31,          Ended December 31,
                                 -------------------------  -------------------------
                                    2001          2002         2001          2002
                                 -----------  ------------  -----------  ------------
<S>                              <C>          <C>           <C>          <C>
REVENUES:                        $         0  $          0  $         0  $         0
--------

EXPENSES:
---------
Contract Services                $         0  $    187,850  $         0  $   189,850
Other Expenses                             0        29,320            0       34,070
Professional Fees                          0         1,500            0        2,197
Total expenses                             0  $    218,670            0      226,117

Loss from Operations             $            $   (218,670)           0  $   (226,117)

OTHER INCOME (Expenses)
-----------------------
Debt Forgiveness                                                         $   118,670

Net Income/loss from operation             0  $  (218,670)            0  $  (107,447)

Loss  / Income Per Share             nil           nil           nil          nil
                                  ==========    ==========   ==========    ==========
Weighted average number of
  common shares outstanding       21,904,000    30,713,958   21,904,000    30,713,958
</TABLE>

<TABLE>
<CAPTION>
                      STATEMENTS OF CASH FLOWS (UNAUDITED)

                                                      Nine Month Period
                                                      Ended December 31,
                                                      ------------------
                                                       2001         2002
                                                   ------------  -----------
<S>                                                <C>           <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (loss)                                  $         0   $ (107,447)
Changes in operating assets and liabilities
  Other Current Assets                                 (50,000)
  Accounts payable                                    (103,962)      86,530
  Other Liabilities                                                   8,394
                                                                 -----------
  Total Adjustments                                   (153,962)      94,924
                                                                 -----------
Net cash provided (used) by operating activities   $  (153,962)  $  (12,523)
CASH FLOWS FROM INVESTING ACTIVITIES:
  Fixed Assets                                               -            -
Net cash provided (used) by investing activities             -            -
CASH FLOWS FROM FINANCING ACTIVITIES:
  Note Payable - Related Party
  Note Payable                                                       16,500
  Stock Issued for Debt Reduction                      154,480
Net Cash Provided for financing activities             154,480       16,500
Increase (decrease) in cash                                518        3,977
Cash  beginning of period                                    0            -

Cash at end of period                              $       518   $    3,977
                                                   ===========   ===========
</TABLE>


                 See accompanying notes to financial statements

                                        4
<PAGE>
                               MEDPLUS CORPORATION
                    NOTES TO FINANCIAL STATEMENTS (UNAUDITED)

1.   GOING  CONCERN  The  Company's  financial  statements  are prepared using
     --------------
     generally  accepted  accounting  principles  applicable to a going concern,
     which contemplates the realization of assets and liquidation of liabilities
     in  the  normal  course  of  business.  However,  the Company does not have
     significant  cash or other material assets, nor does it have an established
     source  of revenues sufficient to cover its operating costs and to allow it
     to continue as a going concern. These factors raise substantial doubt about
     the  Company's  ability  to  continue  as  a  going  concern. The Company's
     continuation  as  a going concern is dependent upon its ability to generate
     sufficient  cash  to  meet  its  obligations  on  a timely basis, to obtain
     financing  as  may  be  required,  and  ultimately  to  attain  successful
     operations. Management is continuing its efforts to obtain additional funds
     needed  for  the  successful  operation  of  the  Company.

2.   BASIS  OF PRESENTATION  The accompanying unaudited consolidated financial
     ----------------------
     statements  of  MEDPLUS  CORPORATION contain all adjustments (consisting of
     only  normal recurring adjustments) which, in the opinion of management are
     necessary to present fairly the financial position of the Company as of the
     periods  ended  December 31, 2001 and December 31, 2002, and the results of
     operations  and  its  cash flows for the three and nine month periods ended
     December  31,  2001 and December 31, 2002. Certain information and footnote
     disclosures  normally  included in financial statements have been condensed
     or omitted pursuant to rules and regulations of the Securities and Exchange
     Commission,  although  the  registrant believes that the disclosures in the
     consolidated  financial  statements  are  adequate  to make the information
     presented  not  misleading.
     Income  Taxes  Deferred  income  taxes  arise  from  temporary  differences
     -------------
     resulting  from  the  Company's  subsidiary  utilizing  the  cash  basis of
     accounting  for  tax purposes and the accrual basis for financial reporting
     purposes.  Deferred  taxes  are  classified  as  current  or  non-current,
     depending on the classification of the assets and liabilities to which they
     relate. Deferred taxes arising from timing differences that are not related
     to an asset or liability are classified as current or non-current depending
     on the periods in which the timing differences are expected to reverse. The
     Company's  previous  principal  temporary differences relate to revenue and
     expenses  accrued  for  financial  purposes,  which  are  not  taxable  for
     financial  reporting purposes. The Company's material temporary differences
     consist  of  bad  debt expense recorded in the financial statements that is
     not deductible for tax purposes and differences in the depreciation expense
     calculated  for  financial  statement  purposes  and  tax  purposes
     As  of  March 31, 2002, the Company has net operating loss carryforwards of
     approximately  $8,632,000 which started expiring in fiscal year 2000. As of
     March  31,  2002,  the Company has recorded a valuation allowance to reduce
     existing  deferred  tax  assets  since  the  assets  are  not  likely to be
     realized.
3.   COMPUTATION OF NET LOSS PER SHARE  Net loss per share is computed by
     ---------------------------------
     dividing  net loss by the weighted average number of shares of common stock
     outstanding.  Options  and  warrants  are not included because their effect
     would  be  antidilutive.
4.   NOTES  PAYABLE  TO RELATED PARTIES  Notes  payable  to related parties, all
     ----------------------------------
     of  which are considered to be current liabilities by their terms or due to
     default,  consist  of  the  following  at  December  31,  2002:

     Unsecured  note  payable  to  a  shareholder  of  the Company, non-interest
     bearing,  due in equal monthly installments of $2,000 from May 1996 through
     April  1997  with a final installment of $123,288 payable on May 1997. This
     note is recorded net of unamortized discount of $5,074 at March 31, 1997 to
     reflect  an  effective  interest  rate of 18%. Payments on this note are in
     default.
                                                                        $116,741
     Unsecured  note payable to shareholder of the Company bearing interest at a
     range  between  10% to 17% depending on shareholder's credit card rate. The
     note  is  payable  on  demand  and  in  default.
                                                                         $21,429
                                                       Total            $138,170


                                        5
<PAGE>
                ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS
                  ---------------------------------------------

LIQUIDITY AND CAPITAL RESOURCES
-------------------------------

At  December  31, 2002 the Company had working capital of ($512,778) compared to
working  capital  of  ($446,831)  at  March  31,  2002.  The decrease of working
capital  primarily  due  to  increase in accounts payable  The Company's current
liabilities  are  higher than its assets due primarily to borrowings in the form
of  promissory  notes from shareholders of the Company and related parties along
with  and  increase  in  accrued  payables  and  expenses.

The  Company's  liquidity  position  is  severely strained.  Liquidity needs are
currently  being  met from short-term borrowing in the form of promissory notes.
Because  the  Company  has  not  achieved  positive cash flow from its operating
activities,  the  company  ceased  normal operations in May 1998.  The Company's
ability to continue operations is dependent upon its ability to raise additional
equity and/or debt financing.  This and other factors raise substantial doubt as
to  the  Company's  ability to continue as a going concern.  Management believes
the  Company  needs approximately $ 250,000 in equity or debt financing in order
to  sustain  operations  for  the  next twelve months following the period ended
December  31,  2002.  On  December  1,  2002 the Company agreed to the terms and
conditions  of a $2,000,000 Installment Financing over a thirty-six month period
arranged  by  Hyland  Capital Advisors.  The general terms of the financing call
for  a  monthly  equity  investment  in  the company at a price of $0.20 (twenty
cents) per share, subject to certain market and pricing conditions. Each monthly
installment  will  be  determined  by  market activity and pricing levels with a
minimum  monthly  installment  to  be  $20,000.00.  The  commencement  of  the
installments  is  subject  to  a registration statement being filed and declared
effective with the Securities and Exchange Commission and upon the completion of
the formal documentation. Although the Company is actively engaged in activities
with intent to raise equity and/or debt financing in order to meet its long-term
liquidity  needs,  there  can  be  no assurance that the Company will be able to
consummate  the  transaction and/or raise the additional financing necessary for
continuing  operations.

RESULTS  OF  OPERATIONS
-----------------------

There  was no revenue derived from the sale of products from the Company for the
three  month  period ended December 31, 2002 or for the three month period ended
December 31, 2001. This attributable to the decline in patient financing with no
employees  to  support  the  financing  activities.
There  were  no  General and Administrative expenses for operations for the nine
month  period  ended  December  31,  2002.  There  were  no  Sales and Marketing
expenses  for  operations  for  the  nine-month  period  ended December 31, 2002

PART II     OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS                                        None
        -----------------

ITEM 2. CHANGES IN SECURITIES                                    None
        ---------------------

ITEM 3. DEFAULTS UPON SENIOR SECURITIES                     None
        -------------------------------

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITIES HOLDER     None
        ----------------------------------------------------

ITEM 5. OTHER INFORMATION
        -----------------

OFFER  AND COMPRIMISE ACCEPTED - On August 7, 2001, the Internal Revenue Service
accepted  an offer of $ 94,500 to settle outstanding payroll tax liabilities and
release liens associated with payroll taxes from 1996 through 1999. The offer is
due  to be paid in January 2002. The accrued payroll taxes have been adjusted in
these financial statements to reflect this settlement. This remains unpaid.


                                        6
<PAGE>
On  December  6, 2002 the company executed an Agreement and Plan of Exchange for
the  acquisition  of  Alternative Finance Advisors Inc. (AFA).  The Agreement is
subject to a number of conditions.  The Company anticipates it will proceed once
all  conditions  are  met.  AFA is a privately held corporation based in Newport
Beach  California,  with offices in Colorado Springs, CO and Ft. Worth, TX.  AFA
specializes  in  the  patient  finance  industry  by  offering financing for the
self-pay  portion  of  medical  bills in hospitals and clinics.  There can be no
assurance  that  all  the conditions will be met and the Company will be able to
consummate  the  transaction.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
        --------------------------------

     a.  Exhibits                    b.  Reports on Form 8-k
         None                            None
Signatures    Pursuant to the requirements of the Securities and Exchange Act of
----------
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.

                                                MEDPLUS CORPORATION

Date:  February 24, 2003                        \By\Tim C. DeHerrera
                                                --------------------
                                                Tim C. DeHerrera / Director


                                        7
<PAGE>